Page last updated: 2024-10-31

ml 7 and Reperfusion Injury

ml 7 has been researched along with Reperfusion Injury in 2 studies

ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, HF1
Li, TB1
Liu, B1
Lou, Z1
Zhang, JJ1
Peng, JJ1
Zhang, XJ1
Ma, QL1
Peng, J1
Luo, XJ1
Lin, HB1
Cadete, VJ1
Sawicka, J1
Wozniak, M1
Sawicki, G1

Other Studies

2 other studies available for ml 7 and Reperfusion Injury

ArticleYear
Inhibition of myosin light chain kinase reduces NADPH oxidase-mediated oxidative injury in rat brain following cerebral ischemia/reperfusion.
    Naunyn-Schmiedeberg's archives of pharmacology, 2015, Volume: 388, Issue:9

    Topics: Animals; Azepines; Brain; Brain Ischemia; Disease Models, Animal; Hydrogen Peroxide; Male; Membrane

2015
Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia-reperfusion injury.
    Journal of proteomics, 2012, Sep-18, Volume: 75, Issue:17

    Topics: Animals; Azepines; Biomechanical Phenomena; Cardiotonic Agents; Electrophoresis, Gel, Two-Dimensiona

2012